NPPB and AL amyloidosis: Moreover, cardiac troponin and N‐terminal pro‐B‐type natriuretic peptide (NT‐pro‐BNP) have been proposed for use as prognostic markers in patients with AL amyloidosis.29–31 However, no biochemical marker is presently available for discriminating between AL‐CMP and TTR‐CMP.